Artivion
AORT27.1954.20% ( +1.095 )
Artivion (AORT)
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and m...
- Open
- 25.960
- High
- 27.250
- Low
- 26.555
- Prev. Close
- 26.100
- Volume
- 26.57K
- Turnover
- 714.80K
- Avg Price
- 26.904
- Bid/Ask Ratio
- --
- Amplitude
- 2.66%
- 52wk High
- 48.250
- Volume Ratio
- 1.17
- Turnover Ratio
- 0.06%
Artivion Analyst Rating
View MoreForecast & Rating
Jul 20, 2026Price forecast
$42.0054.44%
Forecast & RatingStrong buy
8analysts
- Strong buy75.00%
- Buy25.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- StockTitan · Jul 23 at 07:10 AM
Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2026 Financial Results | AORT Stock News
- rttnews · Jul 2 at 09:15 AM
Weekly Buzz: VRTX, APTX Gain FDA Nod; UNCY Disappoints; Ipsen Opens Wallet; VTGN Misses Goal
- Tip Ranks · Jun 29 at 10:15 AM
Artivion: FDA Approval Expands AMDS Market Opportunity; Buy Rating Reiterated with Unchanged $44 Price Target
- PUBT · Jun 29 at 06:01 AM
Artivion wins FDA approval for AMDS Hybrid Prosthesis in acute DeBakey Type I aortic dissection
- StockTitan · Jun 10 at 07:10 AM
Artivion to Participate in the 2026 Truist Securities MedTech Conference | AORT Stock News
- Tip Ranks · Jun 1 at 07:41 AM
Stifel Nicolaus Sticks to Its Buy Rating for Artivion (AORT)
